Meeting
2013 Genitourinary Cancers Symposium
Hypofractionated radiotherapy (66Gy at 3Gy per fraction) for favorable-risk prostate cancer: Long-term outcomes.
Authors
Nita Patel
McGill University Health Centre, Montreal, QC, Canada
Nita Patel , Sergio Faria , Fabio L. Cury , Marc David , Marie Duclos , George Shenouda , Luis Souhami
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 141)
DOI
10.1200/jco.2013.31.6_suppl.141
Abstract #
141
Poster Bd #
J6
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Quality Care Symposium
Impact of radiotherapy practice structure on prostate cancer treatment and outcomes.
First Author: Karen Elizabeth Hoffman
Poster
2024 ASCO Genitourinary Cancers Symposium
Days spent with healthcare contact by patients with metastatic castrate-resistant prostate cancer in the last year of life.
First Author: Daniel Sentana Lledo
Poster
2022 ASCO Genitourinary Cancers Symposium
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.
First Author: David James Carpenter
Poster
2020 Genitourinary Cancers Symposium
Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial.
First Author: David P. Dearnaley